
Put incentives back into compensation: The return of traditional incentive plans
A year ago, we shared how life sciences companies should adjust traditional incentive compensation plans to account for pandemic-driven changes in life sciences commercialization. Now that we’re a little over a year into the COVID-19 pandemic, let’s revisit the state of incentive compensation in the life sciences industry and determine how companies can keep reps motivated amid the shifting commercial landscape.
Read More »